Showing results (461-470 of 558) with videos related to
Sort By:
Pageof 56
Archives of Neurology|April 18, 2000
Subthalamic stimulation in Parkinson disease: a multidisciplinary approachJ L Houeto, P Damier, P B Bejjani, et al.Neuroscience|October 1, 1995
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatumM T Herrero, S J Augood, E C Hirsch, et al.Revue Neurologique|September 24, 2008
[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?]H El Otmani, N Jodoin, S Yaici, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson diseaseB A Faucheux, N Nillesse, P Damier, et al.Neurology|August 10, 2000
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's diseaseB Pillon, C Ardouin, P Damier, et al.Neuroscience Letters|March 15, 1985
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patientsL Pique, S Jegou, X Bertagna, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulationS Rivaud-Péchoux, A I Vermersch, B Gaymard, et al.Neuroscience|September 1, 1993
Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?M T Herrero, E C Hirsch, A Kastner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.Journal of Sleep Research|March 25, 2000
Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremorI Arnulf, B P Bejjani, L Garma, et al.Pageof 56